Published Paper Details:

Comorbidity exists when any two medical or mental conditions co-occur. The predominance of depression is generously higher in populations with medical illnesses than in populations without medical illnesses. Since it was first revealed that depression was linked to higher mortality in individuals recuperating from an acute myocardial infarction (AMI), there has been a growing focus on mood disruption in patients recovering from an AMI. The ENRICHD (Enhancing Recovery in Coronary Heart Disease Patients) clinical trial, which was just completed, was meant to see if treating depression and social isolation after an acute myocardial infarction increases survival (AMI). There was no significant difference in survival between the intervention and control groups in the experiment. Depression may no longer be a risk factor for death following an AMI, which could explain the lack of an intervention impact. Depression is linked to increased patient morbidity and death following an acute myocardial infarction (AMI). Anxiety, on the other hand, has received little attention in this setting, despite the fact that it has been shown to predict in-hospital mortality. Given the potential clinical importance of depression and anxiety after MI, the mixed results for the former and the paucity of evidence on the latter suggest that more research is needed.